GSK Says New Lung-Cancer Drug Shows Benefits at Earlier Stage of Treatment
By Adria CalatayudGSK said its Jideytro drug showed benefits for patients with a type of lung cancer in a clinical trial, a finding that could help the company seek approval for the medicine at an earlier stage of treatment.The U.K. drugmaker said new data for Jideytro--one of the products it obtai…